Patents by Inventor Vineetha EDAVANA

Vineetha EDAVANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T cell compositions with improved phenotypic properties
    Patent number: 11007222
    Abstract: The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions. The composition comprises, in a pharmaceutically acceptable carrier, at least about 106 CD8+ T cells specific for target peptide antigen(s), which comprises T memory stem (TSCM) cells. In various embodiments, the composition is from about 1% to about 100% T memory stem cells, providing for a robust and durable adoptive therapy, as well as providing for T cell engineering advances.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: May 18, 2021
    Assignee: NEXIMMUNE, INC.
    Inventors: Mathias Oelke, Kristi Jones, Sojung Kim, Lauren Suarez, Ken Carter, Scott Carmer, Dan Bednarik, Vineetha Edavana, Emily Lu
  • T CELL COMPOSITIONS WITH IMPROVED PHENOTYPIC PROPERTIES
    Publication number: 20200215115
    Abstract: The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions. The composition comprises, in a pharmaceutically acceptable carrier, at least about 106 CD8+ T cells specific for target peptide antigen(s), which comprises T memory stem (TSCM) cells. In various embodiments, the composition is from about 1% to about 100% T memory stem cells, providing for a robust and durable adoptive therapy, as well as providing for T cell engineering advances.
    Type: Application
    Filed: December 9, 2019
    Publication date: July 9, 2020
    Inventors: Mathias OELKE, Kristi JONES, Sojung KIM, Lauren SUAREZ, Ken CARTER, Scott CARMER, Dan BEDNARIK, Vineetha EDAVANA, Emily LU
  • T CELL COMPOSITIONS WITH IMPROVED PHENOTYPIC PROPERTIES
    Publication number: 20200188435
    Abstract: The present invention provides an isolated cell composition, which in some embodiments is suitable for adoptive immunotherapy, as well as methods of manufacturing the cell compositions and methods of treatment with the cell compositions. The composition comprises, in a pharmaceutically acceptable carrier, at least about 106 CD8+ T cells specific for target peptide antigen(s), which comprises T memory stem (TSCM) cells. In various embodiments, the composition is from about 1% to about 100% T memory stem cells, providing for a robust and durable adoptive therapy, as well as providing for T cell engineering advances.
    Type: Application
    Filed: November 8, 2019
    Publication date: June 18, 2020
    Inventors: Mathias OELKE, Kristi JONES, Sojung KIM, Lauren SUAREZ, Ken CARTER, Scott CARMER, Dan BEDNARIK, Vineetha EDAVANA, Emily LU